Cargando…

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) ranks the sixth prevalent tumors with high mortality globally. Alternative splicing (AS) drives protein diversity, the imbalance of which might act an important factor in tumorigenesis. This study aimed to construct of AS-based prognostic signature and eluc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qianhui, Xu, Hao, Deng, Rongshan, Li, Nanjun, Mu, Ruiqi, Qi, Zhixuan, Shen, Yunuo, Wang, Zijie, Wen, Jingchao, Zhao, Jiaxin, Weng, Di, Huang, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017877/ https://www.ncbi.nlm.nih.gov/pubmed/33794886 http://dx.doi.org/10.1186/s12935-021-01894-z

Ejemplares similares

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance
por: Liu, Chuan, et al.
Publicado: (2020)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
por: Ouyang, Dong, et al.
Publicado: (2020)

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Immunological significance of survival-related alternative splicing in uveal melanoma
por: Kong, Deqian, et al.
Publicado: (2022)

Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A(165b) alternative splicing via regulating SRSF1 and SRPK1
por: Pan, Xiu-wu, et al.
Publicado: (2021)

Prognostic role of alternative splicing events in head and neck squamous cell carcinoma
por: Ding, Yanni, et al.
Publicado: (2020)

Switched alternative splicing events as attractive features in lung squamous cell carcinoma
por: He, Boxue, et al.
Publicado: (2022)

hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing
por: Peng, Wei-zhao, et al.
Publicado: (2019)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression
por: Peng, Wei-zhao, et al.
Publicado: (2021)

Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis
por: Xu, Hao, et al.
Publicado: (2021)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9
por: Li, Weihang, et al.
Publicado: (2021)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

The expression and clinical significance of HERC4 in breast cancer
por: Zhou, Hui, et al.
Publicado: (2013)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
por: Lin, Zhen, et al.
Publicado: (2021)

Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
por: Huang, Jing, et al.
Publicado: (2019)

Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma
por: Xu, Yunfeng, et al.
Publicado: (2021)

Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
por: Wang, Xuemin, et al.
Publicado: (2021)

Intraoperative Neuromonitoring Auxiliary Significance of DNEP for MEP-positive Event During Severe Spinal Deformity Surgery
por: Chen, Jian, et al.
Publicado: (2022)

Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
por: Chen, Lujun, et al.
Publicado: (2018)

The biological function and clinical significance of STIL in osteosarcoma
por: Ji, Shu-fan, et al.
Publicado: (2021)

Significance of alternative splicing in cancer cells
por: Qi, Fei, et al.
Publicado: (2020)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2021)

Alternative splicing event associated with immunological features in bladder cancer
por: Yu, Xinbo, et al.
Publicado: (2023)

Altered splicing associated with the pathology of inflammatory bowel disease
por: Berger, Kiera, et al.
Publicado: (2021)

Alternative splicing signatures in preimplantation embryo development
por: Tian, Geng G., et al.
Publicado: (2020)

Role of alternative splicing signatures in the prognosis of glioblastoma
por: Xie, Zu‐cheng, et al.
Publicado: (2019)

An alternative splicing signature in human Crohn’s disease
por: Li, Daowei, et al.
Publicado: (2021)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gcfkbdptmg1h1j6a65k9mjh15g